AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16354 ↗At a glance
Journal article in British Journal of Pharmacology, 2024. Written by Yi-Ting Huang and 6 co-authors. Institution: Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan. Major MEDLINE topics: Aminoimidazole Carboxamide, AMP-Activated Protein Kinases, Skin. Cited 2 times so far (Crossref); 57 references. Funded by: Ministry of Science and Technology, Taiwan, MacKay Memorial Hospital.
Abstract (original language)
Background and Purpose The interleukin (IL)‐36 pathway is a critical player in the pathogenesis of pustular psoriasis. However, therapies targeting this pathway are limited or unaffordable (e.g. the anti‐IL‐36 receptor antibody). AMP‐activated protein kinase (AMPK), a regulator of cellular energy and metabolism, is known to participate in inflammatory diseases. However, its role in IL‐36‐induced skin inflammation remains unclear. Therefore, we sought to investigate the role of AMPK signals in regulating IL‐36‐induced responses in the skin. Experimental Approach IL‐36‐stimulated primary normal human epidermal keratinocytes (NHEKs) and IL‐36‐injected (intradermally) BALB/c mice served as the cell and animal models, respectively. Additionally, 5‐aminoimidazole‐4‐carboxamide riboside (AICAR) and A769662 served as AMPK activators. Key Results AICAR and A769662 significantly suppressed the IL‐36‐induced IL‐8 (CXCL8) and CCL20 production from NHEKs. IL‐36‐induced IκBζ protein expression was prominently reduced and IKK/IκBα phosphorylation was attenuated by AICAR and A769662. Conversely, AMPKα knockdown increased IκBζ protein expression and IKK/IκBα phosphorylation in IL‐36‐treated NHEKs. Furthermore, AICAR and A769662 enhanced IL‐36‐induced‐IκBζ protein degradation via the proteasome‐dependent but not the lysosome‐dependent pathway. Pretreatment of NHEKs with IL‐36 slightly suppressed the AICAR‐ and A769662‐triggered phosphorylation of AMPK and acetyl‐CoA carboxylase. In the mouse model, topical application of AICAR significantly reduced ear swelling, redness, epidermal thickening, neutrophil infiltration and inflammatory and antimicrobial peptide gene expression. Conclusion and Implications AMPK activation suppresses IL‐36‐induced IL‐8 and CCL20 release by regulating IκBζ expression in keratinocytes and reduces IL‐36‐induced skin inflammation in mice, suggesting that AMPK activation is a potential strategy for treating patients with IL‐36‐mediated inflammatory skin disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Nursing, MacKay Medical College, New Taipei City, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
- Department of Dermatology, MacKay Memorial Hospital, Taipei, Taiwan.
- MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
- Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
ORCID profiles: Po-Hsuan Lu, Nan-Lin Wu
Funding
- Ministry of Science and Technology, Taiwan
- MacKay Memorial Hospital
Cite
APA
Huang, Y. T., Chiu, L. Y., Lu, P. H., Hsiao, P. F., Wang, J. Y., Lu, P. H., & Wu, N. L. (2024). AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin. British Journal of Pharmacology. https://doi.org/10.1111/bph.16354
Vancouver
Huang YT, Chiu LY, Lu PH, Hsiao PF, Wang JY, Lu PH, et al. AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin. British Journal of Pharmacology. 2024. doi:10.1111/bph.16354
BibTeX
@article{Huang2024,
author = {Huang, Yi-Ting and Chiu, Ling-Ya and Lu, Po-Hsuan and Hsiao, Pa-Fan and Wang, Jen-Yu and Lu, Ping-Hsun and Wu, Nan-Lin},
title = {AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16354}
}
EUVIMED